THC saliva testing in Australia, testing, laws, and future research

THC saliva testing is now a routine part of roadside drug testing across Australia. Many patients using prescribed medicinal cannabis ask the same question, how accurate are these tests, what exactly are police detecting, and is the law likely to change. This guide explains how THC saliva testing works, what the science says about reliability, how laws differ across Australia, and what current Victorian government-funded research is exploring for the future.

Key takeaways

• Saliva tests detect THC presence, not impairment
• THC can be detected long after the psychoactive effects have worn off
• Prescribed medicinal cannabis currently offers no legal defence to THC-positive roadside tests
• Victorian government research is exploring saliva THC thresholds that better reflect actual impairment

What does a saliva drug test detect

Roadside oral fluid tests detect the presence of delta-9-tetrahydrocannabinol (THC), which is the main psychoactive compound in cannabis. These tests do not measure impairment. They detect whether THC is present above a threshold, typically around 25 nanograms per millilitre (ng/mL) for the screening device, with laboratory confirmation at approximately 10 ng/mL [1–3].

This means that a patient could test positive for THC many hours after using their prescribed cannabis, even when they feel completely unaffected and are functioning normally [4].

How does the test work

The standard test used in Australia is a point-of-collection oral fluid immunoassay device, such as the Dräger DrugTest 5000 or Securetec DrugWipe. A small sample of saliva is collected from the inner cheek or tongue. The device produces a preliminary positive or negative result within about five to ten minutes.

If the initial screen is positive, a second oral fluid sample is usually taken and sent for laboratory confirmatory testing using liquid chromatography–mass spectrometry (LC–MS/MS). This confirmatory step is far more accurate but results take days to return [1–3].

How accurate is the saliva test

Screening devices are designed to be sensitive rather than specific. This means:

• True positive rates for THC detection at the screening stage vary from approximately 69 to 97 percent depending on the study and device used [2–3]
• False positive rates are generally low but do occur
• False negatives are more common, meaning some cannabis users may pass the screening despite having consumed THC recently [3]

The sensitivity gap means that roadside tests can produce both false positives (although rare) and false negatives (more common). Confirmatory laboratory testing is far more reliable, but the initial roadside result often determines whether further action is taken [2–3].

How long does THC stay in saliva

Detection times vary significantly based on dose, frequency, formulation and method of use. In general:

• Occasional use may be detectable for 6 to 12 hours
• Regular or heavy use may be detectable for 12 to 48 hours or longer
• Direct oral contamination from smoking or vaporising can extend early detection windows [6–7]

Unlike alcohol testing, there is no reliable roadside threshold that separates impairment from non-impaired states.

Do terpenes, temperature or vaping method change detection

How cannabis is consumed can influence how THC enters saliva. Vaporising flower at different temperatures changes aerosol particle size and oral deposition. Terpene content also affects absorption and subjective effects terpenes and temperature.

Terpenes such as myrcene, limonene, linalool and caryophyllene modify how THC feels but do not reduce detection risk. Even products with lower THC percentages may still produce saliva THC positives due to the entourage effect and terpene synergy.

Is there a legal defence for prescribed patients

Currently, having a valid prescription for medicinal cannabis is not a defence to THC-positive roadside drug testing under state or territory driving laws in most of Australia. The legal framework penalises the presence of THC rather than the impairment caused by it.

This creates a significant dilemma for patients who are legally prescribed THC-containing medication but face prosecution for using it, even if they drive well after effects have worn off.

Where do the laws differ across Australia

Tasmania

Tasmania is the only state that provides a partial statutory pathway for prescribed medicinal cannabis patients. Under recent amendments, patients who hold a valid prescription can raise this as a defence in court if charged with drug driving involving THC. However, this is a court process, not a roadside exemption. Patients can still be stopped, tested, and charged but may use the prescription as a legal defence during proceedings [5]. This is the only jurisdiction in Australia where law has been updated to reflect the growing number of legal medicinal cannabis patients.

Victoria

Victoria does not currently provide a prescription-based defence but has funded ongoing research into saliva testing accuracy and impairment modelling. Victoria's approach may evolve once that research is completed and findings are published. The state government has signalled interest in an evidence-based approach toward impairment-based testing.

New South Wales, Queensland, South Australia, Western Australia, Northern Territory and ACT

These jurisdictions continue to apply zero-tolerance roadside drug driving laws. If THC is detected in saliva, the offence is made out regardless of prescription status [5–7].

Penalties typically include:

• Immediate licence suspension
• Court fines
• Demerit points
• Possible criminal record

There is currently no medical exemption in these states.

Will the law change in the future

Momentum is building toward reform. The Victorian state government has funded ongoing research into saliva testing accuracy, real world impairment and medicinal cannabis pharmacokinetics [8]. These projects aim to determine whether roadside testing fairly reflects actual driving risk.

National medical and legal bodies are also increasingly calling for a move away from presence-based testing toward true impairment testing, similar to how alcohol is managed [9].

However, reform will require:

• Completion and publication of funded research programs
• Political will at both state and federal levels
• Development of validated impairment testing methods for THC
• Public education campaigns to separate cannabis impairment from cannabis presence

In the meantime, prescribed patients must be aware of the legal risks. Any detectable THC in saliva can lead to charges in most states, regardless of whether impairment exists.

Summary

THC saliva testing across Australia detects the presence of THC, not impairment. Screening devices are useful but imperfect. Detection windows vary depending on how and when cannabis is used. Prescribed patients currently have no defence in most states (with the exception of Tasmania). Current research may eventually change how THC driving is regulated, but for now, any detectable THC carries legal risk.

References

1. Verstraete A. Oral fluid testing. Detection of drugs in saliva. Ther Drug Monit. 2004. 2. Drummer OH. Drug testing in oral fluid. Clin Biochem Rev. 2005. 3. Pil K et al. Sensitivity and specificity of roadside oral fluid drug tests. Accid Anal Prev. 2020. 4. Hartman RL, Huestis M. Cannabis effects on driving skills. Clin Chem. 2013. 5. Australian Government National Transport Commission. Roadside drug testing in Australia, technical standards. 2022. 6. Huestis M. Oral fluid testing for THC. Drug Test Anal. 2009. 7. Verstraete A. Detection times of drugs of abuse in saliva. Ther Drug Monit. 2004. 8. Lachenmeier DW et al. THC contamination in CBD products. Food Control. 2020. 9. NSW Road Transport Act and regulations. Drug driving provisions. 10. VicRoads Drug Driving Laws. Current roadside testing framework. 11. Victorian Government Department of Justice. Medicinal cannabis and driving research program.